Business Wire

Ant International Shares Local Investment, AI Innovation and Partnerships Growth Strategy at MyFintech Week 2025

13.8.2025 03:48:00 CEST | Business Wire | Press Release

Share

Ant International:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250812873954/en/

Making payments at Stellar Coffee, a cafe in Kuala Lumpur popular with tourists, is now easier for users of Alipay+'s 15 partner e-wallets across key travel markets such as Singapore and Indonesia

Increasing Investments in Ant International's Digital Business Centre in Kuala Lumpur

Ant International, headquartered in Singapore, has been expanding its human and technology investments in Malaysia as a regional technology and commercial hub. The Ant International Digital Business Centre in Kuala Lumpur, created in 2024, now houses close to 800 engineers and professionals working across AI R&D, technology, security, product development and customer service to serve Ant's global clients. "We are accelerating hiring in Kuala Lumpur, and expecting another 25% staff growth in the coming months," said Feagin.

According to Feagin, Ant International's investment in Malaysia aligns with the Malaysia Digital Economy Blueprint, which outlines a framework for the country's digital transformation, including talent development and the creation of a digitally inclusive society.

Malaysia has emerged as a key Southeast Asian market, and is among the leaders in QR-code adoption when it comes to digital payments. Its national QR payments scheme, DuitNow QR, has 2.5 million merchants registered, almost three times the number of traditional point-of-sale terminals in Malaysia.

Expanding Partnerships to Enhance Regional and Global Travel & Trade Connectivity

"Innovation and collaboration are necessary ingredients to drive genuinely inclusive, sustainable growth," said Feagin. Ant International is expanding cooperation with Malaysian regulators and partners to promote digitalization of cross-border trade and commerce for Alipay+ and its other business lines.

Alipay+, the global wallet gateway service under Ant International, has been a key partner of PayNet, Malaysia's national payments network provider, to support travellers using global wallets to pay on DuitNow, the country's national real-time payments network.

In 2024, Malaysia welcomed close to 38m foreign visitors, a 31.1 percent increase compared with the year before. That same year, more than 80 percent of inbound QR payments to Malaysia via DuitNow were made through Alipay+.

"We look forward to expanding our relationship with PayNet and local businesses to maximize travel and cross-border commerce for Malaysia, including bringing on global tax refunds, remittance connectivity, and AI-powered travel services," said Feagin.

WorldFirst, Ant International's global business account service, secured a Class A Money Services Business license from the Central Bank of Malaysia in August to better support Malaysian and regional SMEs to grow international business. As of June 2025, WorldFirst has served over 1.2 million SMEs globally, with a total transaction volume of over 300 bn USD.

“Solutions like these enable small merchants to focus on the things they want to do – attract new customers, increase revenues, and give back to their communities,” said Feagin.

Supercharging digital economy through AI

Technology cooperation and capacity building for fintech partners has been a focus for Ant International. In June 2025, it introduced Alipay+ Cockpit, an AI-as-a-Service platform that enables fintech businesses to develop their own AI growth and security tools tailored to the complex commerce and financial landscape of emerging markets.

"Democratizing AI for emerging markets and small businesses is our core mission," Feagin said. "Ant International is working with partners and regulators to develop a future-ready Trusted AI architecture. While regional businesses make fuller use of agentic AI tools for growth, they should also should also be able to rely on an AI security platform supported by compliance knowledge, threat detection and combat capabilities."

Ant International is introducing a range of new AI tools to Malaysian partners, including Alipay+ EasySafePay 360, an account protection program for users of participating Alipay+ mobile payment partners. It uses AI-powered risk-management solutions to safeguard transactions and offers money-back guarantees for verified unauthorised transactions.

“Global shifts as we see today present huge challenges, but also new opportunities and openings for a vibrant, young economy like Malaysia," said Feagin. "We look forward to expanding our partnerships here, learning more, and contributing more to talent development and technology advancement across the country."

View source version on businesswire.com: https://www.businesswire.com/news/home/20250812873954/en/

Contacts

Ant International
Alex Goh
alex.goh@ant-intl.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye